Knoll/UCSF agreement allows publication of Synthroid study; Knoll will present contrary conclusions.
Executive Summary
KNOLL/UCSF AGREEMENT WILL ALLOW PUBLICATION OF DONG SYNTHROID ARTICLE and will provide for a forum where Knoll can present its view of University of California-San Francisco researcher Betty Dong's study of Knoll's Synthroid and competing levothyroxine products. Dong conducted her study at Knoll's request; the manuscript was withdrawn from the Journal of the American Medical Association "under pressure from Knoll," FDA charged in a Nov. 7 letter ("The Pink Sheet" Nov. 18, p. 3).